Your session is about to expire
← Back to Search
Diagnostic imaging with Copper Cu 64 PSMA I&T for Prostate Adenocarcinoma (Solar-Recur Trial)
Solar-Recur Trial Summary
This trial is testing a new imaging technique using a radioactive substance called copper Cu 64 PSMA I&T injection to detect recurrent prostate cancer in patients who have previously undergone surgery or radiation therapy for prostate cancer
Solar-Recur Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSolar-Recur Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2020 Phase 4 trial • 711 Patients • NCT02175030Solar-Recur Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
In how many distinct clinics is this experimental investigation currently being conducted?
"Eleven facilities, including XCancer in Omaha, Tower Urology in Newport Beach, and Hoag Memorial Hospital Presbyterian in Tampa, among others, are currently active sites for this clinical trial."
Are patients currently being actively enrolled in this ongoing medical study?
"As per clinicaltrials.gov, this study is currently in the recruitment phase. The trial was first listed on 4/1/2024 and last revised on 4/23/2024."
What is the total number of individuals currently enrolled in this medical study?
"A total of 200 eligible individuals are sought to enroll in this research endeavor. Potential participants have the opportunity to join from various locations, including XCancer located in Omaha, Nebraska and Tower Urology situated in Newport Beach, Florida."
What are the potential risks associated with utilizing Copper Cu 64 PSMA I&T in diagnostic imaging procedures for individuals?
"Our team at Power has rated the safety of Diagnostic imaging with Copper Cu 64 PSMA I&T as a 3 on our scale. This rating aligns with it being in Phase 3, indicating existing efficacy data and robust safety records from multiple evaluations."
Share this study with friends
Copy Link
Messenger